Wolverine Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-19
| Closed | -$7.65K | – | 1418 |
|
|
2024
Q4 | $7.65K | Buy |
+19
| New | +$7.65K | ﹤0.01% | 965 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1474 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1482 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 1561 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1651 |
|
|
2021
Q3 | – | Sell |
-1,189
| Closed | -$239K | – | 2128 |
|
|
2021
Q2 | $239K | Buy |
1,189
+545
| +85% | +$110K | ﹤0.01% | 1011 |
|
|
2021
Q1 | $138K | Buy |
644
+582
| +939% | +$125K | ﹤0.01% | 1142 |
|
|
2020
Q4 | $14K | Buy |
+62
| New | +$14K | ﹤0.01% | 1162 |
|
|
2020
Q3 | – | Sell |
-7
| Closed | -$2K | – | 1539 |
|
|
2020
Q2 | $2K | Buy |
+7
| New | +$2K | ﹤0.01% | 1160 |
|
|
2017
Q4 | – | Sell |
-21,969
| Closed | -$3.34M | – | 1166 |
|
|
2017
Q3 | $3.34M | Buy |
21,969
+19,169
| +685% | +$2.91M | 0.04% | 179 |
|
|
2017
Q2 | $360K | Buy |
+2,800
| New | +$360K | ﹤0.01% | 517 |
|
|
2015
Q1 | – | Sell |
-889
| Closed | -$105K | – | 1363 |
|
|
2014
Q4 | $105K | Sell |
889
-64,000
| -99% | -$7.56M | ﹤0.01% | 824 |
|
|
2014
Q3 | $7.29M | Hold |
64,889
| – | – | 0.15% | 120 |
|
|
2014
Q2 | $6.14M | Buy |
64,889
+500
| +0.8% | +$47.3K | 0.13% | 116 |
|
|
2014
Q1 | $4.55M | Buy |
64,389
+39,900
| +163% | +$2.82M | 0.1% | 156 |
|
|
2013
Q4 | $1.82M | Buy |
+24,489
| New | +$1.82M | 0.04% | 296 |
|
|
2013
Q3 | – | Sell |
-2,965
| Closed | -$237K | – | 1497 |
|
|
2013
Q2 | $237K | Buy |
+2,965
| New | +$237K | 0.01% | 733 |
|